Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
Completed · Phase 2 · Has a placebo group
Conditions studied: Prostate Cancer
In brief
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent or delay the development of early cancer. Soy isoflavones may be effective in delaying the development of early prostate cancer. PURPOSE: This randomized phase II trial is studying different regimens of soy isoflavones to compare how well they work in treating patients who are undergoing radical prostatectomy for stage I or stage II prostate cancer (adenocarcinoma).
Key facts
- Study ID
- NCT00078923
- Run by
- Barbara Ann Karmanos Cancer Institute
- People needed
- 32
- Starts
- 2001-11-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2014-03-05
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.